PARK7 and non-small cell lung carcinoma: It has been reported that mutations in KEAP1/NRF2 [54] and higher expression level of DJ1 [17], NQO1 [31], TP53 [55], CUL3 [56] and PRDX5 [57] are associated with poor survival of patients with NSCLC.